Elevated tumor markers in a benign lung disease

Area of Science:

• Pulmonology
• Oncologic Markers
• Pathophysiology

Background:

• Pulmonary sequestration (PS) is a congenital lung malformation.
• Elevated levels of carbohydrate antigen 19-9 (CA19-9) have been observed in PS patients, but the underlying mechanism is unclear.

Purpose of the Study:

• To investigate the pathophysiological mechanism of elevated CA19-9 in PS.
• To evaluate CA19-9 as a potential diagnostic marker for PS.

Main Methods:

• Serum CA19-9 levels were measured in PS patients, pneumonia patients, and healthy controls.
• Immunohistochemical analysis was used to detect CA19-9 expression in PS tissues.
• Pathological changes in PS tissues were assessed using Hematoxylin-eosin staining.

Main Results:

• PS patients exhibited significantly higher serum CA19-9 levels compared to controls.
• CA19-9 was detected in 70% of PS tissues, primarily in bronchial mucus.
• Serum CA19-9 levels decreased post-surgery, correlating with tissue damage.

Conclusions:

• Abnormal columnar epithelia in PS tissues generate CA19-9, which enters circulation following alveolar damage.
• CA19-9 shows potential as an adjunctive diagnostic marker for pulmonary sequestration.